Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000418367 | SCV000530784 | uncertain significance | not provided | 2021-01-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function Has not been previously published as pathogenic or benign to our knowledge Observed in 0.0025% (7/280636 alleles) in large population cohorts, and no individuals are reported as homozygous (Lek et al., 2016) |
Invitae | RCV002230065 | SCV000627327 | uncertain significance | Osteogenesis imperfecta type I; Ehlers-Danlos syndrome, classic type, 1 | 2022-07-06 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 388473). This variant has not been reported in the literature in individuals affected with COL1A2-related conditions. This variant is present in population databases (rs779303344, gnomAD 0.006%). This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 948 of the COL1A2 protein (p.Arg948Ser). |
Revvity Omics, |
RCV000418367 | SCV003833432 | uncertain significance | not provided | 2022-05-31 | criteria provided, single submitter | clinical testing |